Literature DB >> 26359968

Response to: Letter to the Editor Regarding the Article "Thyrotropin Suppression Increases the Risk of Osteoporosis Without Decreasing Recurrence in ATA Low- and Intermediate-Risk Patients with Differentiated Thyroid Carcinoma".

Laura Boucai1, Laura Y Wang2, Andrew W Smith3, Frank L Palmer2, Azhar Mahrous1, R Michael Tuttle1, James A Fagin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26359968      PMCID： PMC6916527          DOI： 10.1089/thy.2015.0369

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  4 in total

1.  Letter to the Editor Regarding the Article "Thyrotropin Suppression Increases the Risk of Osteoporosis Without Decreasing Recurrence in ATA Low- and Intermediate-Risk Patients with Differentiated Thyroid Carcinoma".

Authors:  Peter Schneider; Rita Schneider; Mara Schneider; Christoph Reiners
Journal:  Thyroid       Date:  2015-08-14       Impact factor: 6.568

2.  Effects of levothyroxine on bone mineral density, muscle force, and bone turnover markers: a cohort study.

Authors:  Rita Schneider; Mara Schneider; Christoph Reiners; Peter Schneider
Journal:  J Clin Endocrinol Metab       Date:  2012-09-13       Impact factor: 5.958

3.  Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma.

Authors:  Laura Y Wang; Andrew W Smith; Frank L Palmer; R Michael Tuttle; Azhar Mahrous; Iain J Nixon; Snehal G Patel; Ian Ganly; James A Fagin; Laura Boucai
Journal:  Thyroid       Date:  2014-12-16       Impact factor: 6.568

4.  Subclinical thyroid dysfunction and fracture risk: a meta-analysis.

Authors:  Manuel R Blum; Douglas C Bauer; Tinh-Hai Collet; Howard A Fink; Anne R Cappola; Bruno R da Costa; Christina D Wirth; Robin P Peeters; Bjørn O Åsvold; Wendy P J den Elzen; Robert N Luben; Misa Imaizumi; Alexandra P Bremner; Apostolos Gogakos; Richard Eastell; Patricia M Kearney; Elsa S Strotmeyer; Erin R Wallace; Mari Hoff; Graziano Ceresini; Fernando Rivadeneira; André G Uitterlinden; David J Stott; Rudi G J Westendorp; Kay-Tee Khaw; Arnuf Langhammer; Luigi Ferrucci; Jacobijn Gussekloo; Graham R Williams; John P Walsh; Peter Jüni; Drahomir Aujesky; Nicolas Rodondi
Journal:  JAMA       Date:  2015-05-26       Impact factor: 56.272
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.